vs

Side-by-side financial comparison of enCore Energy Corp. (EU) and Wave Life Sciences Ltd. (WVE). Click either name above to swap in a different company.

enCore Energy Corp. is the larger business by last-quarter revenue ($12.4M vs $8.7M, roughly 1.4× Wave Life Sciences Ltd.). enCore Energy Corp. runs the higher net margin — -173.9% vs -580.2%, a 406.2% gap on every dollar of revenue. enCore Energy Corp. produced more free cash flow last quarter ($7.2M vs $-46.3M).

Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.

BIT Life Sciences is a for profit meetings, incentives, conferencing, exhibitions (MICE) company based in Dalian, China, that specializes in arranging multiple scientific congresses that have been described as "predatory". The company is part of a wave of organizations that have appeared in China in the past several years noted for arranging congresses with little academic merit and with the primary aim of generating revenue rather than scientific knowledge sharing. Papers submitted are usual...

EU vs WVE — Head-to-Head

Bigger by revenue
EU
EU
1.4× larger
EU
$12.4M
$8.7M
WVE
Higher net margin
EU
EU
406.2% more per $
EU
-173.9%
-580.2%
WVE
More free cash flow
EU
EU
$53.5M more FCF
EU
$7.2M
$-46.3M
WVE

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
EU
EU
WVE
WVE
Revenue
$12.4M
$8.7M
Net Profit
$-21.5M
$-50.5M
Gross Margin
37.9%
Operating Margin
-135.9%
-606.5%
Net Margin
-173.9%
-580.2%
Revenue YoY
-55.8%
Net Profit YoY
-53.3%
EPS (diluted)
$-0.11
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EU
EU
WVE
WVE
Q4 25
$12.4M
Q3 25
$8.9M
Q2 25
$3.7M
$8.7M
Q1 25
$18.2M
$9.2M
Q2 24
$19.7M
Q1 24
$12.5M
Q4 23
$29.1M
Q3 23
$49.2M
Net Profit
EU
EU
WVE
WVE
Q4 25
$-21.5M
Q3 25
$-4.8M
Q2 25
$-6.3M
$-50.5M
Q1 25
$-24.2M
$-46.9M
Q2 24
$-32.9M
Q1 24
$-31.6M
Q4 23
$-16.3M
Q3 23
$7.3M
Gross Margin
EU
EU
WVE
WVE
Q4 25
37.9%
Q3 25
43.8%
Q2 25
30.8%
Q1 25
-0.1%
Q2 24
Q1 24
Q4 23
Q3 23
Operating Margin
EU
EU
WVE
WVE
Q4 25
-135.9%
Q3 25
-158.2%
Q2 25
-526.1%
-606.5%
Q1 25
-85.7%
-542.8%
Q2 24
-177.7%
Q1 24
-274.8%
Q4 23
-64.3%
Q3 23
9.0%
Net Margin
EU
EU
WVE
WVE
Q4 25
-173.9%
Q3 25
-53.7%
Q2 25
-172.7%
-580.2%
Q1 25
-132.9%
-510.9%
Q2 24
-167.2%
Q1 24
-251.7%
Q4 23
-55.9%
Q3 23
14.7%
EPS (diluted)
EU
EU
WVE
WVE
Q4 25
$-0.11
Q3 25
$-0.03
Q2 25
$-0.03
$-0.31
Q1 25
$-0.13
$-0.29
Q2 24
$-0.25
Q1 24
$-0.24
Q4 23
$-0.14
Q3 23
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EU
EU
WVE
WVE
Cash + ST InvestmentsLiquidity on hand
$52.4M
$208.5M
Total DebtLower is stronger
$110.0M
Stockholders' EquityBook value
$229.2M
$139.3M
Total Assets
$430.4M
$252.4M
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EU
EU
WVE
WVE
Q4 25
$52.4M
Q3 25
$91.9M
Q2 25
$26.9M
$208.5M
Q1 25
$29.7M
$243.1M
Q2 24
$154.0M
Q1 24
$180.9M
Q4 23
$200.4M
Q3 23
$139.9M
Total Debt
EU
EU
WVE
WVE
Q4 25
$110.0M
Q3 25
$109.3M
Q2 25
Q1 25
Q2 24
Q1 24
Q4 23
Q3 23
Stockholders' Equity
EU
EU
WVE
WVE
Q4 25
$229.2M
Q3 25
$248.6M
Q2 25
$264.7M
$139.3M
Q1 25
$267.9M
$171.8M
Q2 24
$-3.5M
Q1 24
$25.4M
Q4 23
$39.6M
Q3 23
$-40.5M
Total Assets
EU
EU
WVE
WVE
Q4 25
$430.4M
Q3 25
$441.9M
Q2 25
$359.4M
$252.4M
Q1 25
$362.6M
$288.3M
Q2 24
$208.8M
Q1 24
$235.3M
Q4 23
$274.9M
Q3 23
$199.9M
Debt / Equity
EU
EU
WVE
WVE
Q4 25
0.48×
Q3 25
0.44×
Q2 25
Q1 25
Q2 24
Q1 24
Q4 23
Q3 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EU
EU
WVE
WVE
Operating Cash FlowLast quarter
$12.9M
$-46.0M
Free Cash FlowOCF − Capex
$7.2M
$-46.3M
FCF MarginFCF / Revenue
57.8%
-532.5%
Capex IntensityCapex / Revenue
46.7%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-45.0M
$-170.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EU
EU
WVE
WVE
Q4 25
$12.9M
Q3 25
$-20.3M
Q2 25
$-9.9M
$-46.0M
Q1 25
$-7.7M
$-63.0M
Q2 24
$-27.5M
Q1 24
$-33.4M
Q4 23
$-33.2M
Q3 23
$-34.5M
Free Cash Flow
EU
EU
WVE
WVE
Q4 25
$7.2M
Q3 25
$-26.3M
Q2 25
$-14.1M
$-46.3M
Q1 25
$-11.7M
$-63.2M
Q2 24
$-27.5M
Q1 24
$-33.8M
Q4 23
$-33.6M
Q3 23
$-34.7M
FCF Margin
EU
EU
WVE
WVE
Q4 25
57.8%
Q3 25
-296.6%
Q2 25
-385.2%
-532.5%
Q1 25
-64.1%
-688.9%
Q2 24
-139.8%
Q1 24
-270.0%
Q4 23
-115.6%
Q3 23
-70.4%
Capex Intensity
EU
EU
WVE
WVE
Q4 25
46.7%
Q3 25
68.0%
Q2 25
115.1%
3.5%
Q1 25
21.7%
1.8%
Q2 24
0.3%
Q1 24
3.3%
Q4 23
1.2%
Q3 23
0.4%
Cash Conversion
EU
EU
WVE
WVE
Q4 25
Q3 25
Q2 25
Q1 25
Q2 24
Q1 24
Q4 23
Q3 23
-4.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons